Cody Genetics

Revolutionizing livestock breeding with innovative gene-editing technology to produce sexed semen and improve animal welfare.

Biotechnology
Active
Edinburgh, United Kingdom Founded 2020
Website ↗
Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2020
Headcount
—
HQ
Edinburgh, United Kingdom
Sector
Biotechnology

About

Cody Genetics is an animal biotechnology company that applies gene-editing technology, specifically CRISPR-Cas9, to benefit animal farming. The company focuses on creating bulls and boars that produce sexed semen, aiming to increase profitability, improve sustainability by reducing waste, and eliminate inhumane practices such as culling male chicks and swine castration. Cody Genetics partners with leading institutions like Tel Aviv University and Roslin Technologies to develop its technology and plans to establish a global network of veterinary embryology laboratories.

Q&A

What is Cody Genetics' primary focus?
Cody Genetics is an animal biotechnology company that applies gene-editing technology, specifically CRISPR-Cas9, to create bulls and boars that produce sexed semen, aiming to increase profitability, improve sustainability, and eliminate inhumane practices in animal farming.
When was Cody Genetics founded?
Cody Genetics was founded in 2020.
Who are the founders of Cody Genetics?
The founders of Cody Genetics are Yaniv Dolev, who serves as Founder & CEO, and Glen Illing, who serves as Founder & Chairman.
What technology does Cody Genetics primarily use?
Cody Genetics primarily uses CRISPR-Cas9 gene-editing technology.
What are Cody Genetics' target customer segments?
Cody Genetics targets Animal Breeding Companies and Farmers.
Where is Cody Genetics headquartered?
Cody Genetics is headquartered in Edinburgh, United Kingdom.
With which institutions does Cody Genetics partner?
Cody Genetics partners with leading institutions such as Tel Aviv University and Roslin Technologies.
What is Cody Genetics' business model?
Cody Genetics operates on a B2B business model.

Team · 2

Yaniv Dolev
Founder · Founder & CEO
Glen Illing
Founder · Founder & Chairman

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)